Adults may have an increased risk for new-onset or recurrent thyroid eye disease in the 28 days after receiving a COVID-19 vaccine dose, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
“COVID-19 vaccines are associated with a 3.2-fold increased risk to develop thyroid eye disease, an autoimmune inflammation of orbital tissues, between 1 and 28 days following administration,” Ilaria Muller, MD, PhD, assistant professor in endocrinology and metabolism in the department of clinical sciences and community health at University of Milan, told